Visby Medical extends Series E round to include an additional $35 million, totaling more than $135 million raised.
Visby Medical’s CEO reaffirms support for women’s healthcare access, announcing travel expense reimbursement for employees for out-of-state pregnancy-related care.
Offering a high-quality scientific meeting covering all aspects in the field of chlamydia research, this symposium provides an excellent opportunity for specialists and trainees in sexual health, HIV medicine, public health, microbiology, epidemiology and behavioral science to share their ideas and experiences.
AACC selects Visby Medical as a finalist for the 2022 Disruptive Technology Award for its handheld point-of-care PCR diagnostic technology.
Visby Medical today announced Everett Cunningham has been appointed to the company’s Board of Directors.
Respiratory diseases are a leading cause of death worldwide. Get an overview of the most common respiratory diseases, their causes, and treatments.
COVID, Influenza A and B, and RSV may be similar in symptoms, but they need to be treated differently. Learn the difference here.
Early treatment prevents spreading the infection to others. If you are sexually active, it is important to get tested regularly at your healthcare provider, an urgent care, or other local clinic that specializes in treating these infections. Testing is the only way to know for sure if you have an STI.
Visby Medical Will Exhibit at the APHL 2022 Annual Conference, a hybrid event for the public health laboratory (PHL) community.
Visby Medical will exhibit at the UCA/CUCM 2022 Annual Convention. UCA is a trade and professional association in urgent care with more than 3,700 member centers representing urgent care clinical and business professionals from the United States and abroad.